Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 03 tags : Cel save search
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2021 Financial Results
Published: 2022-03-03 (Crawled : 22:00) - globenewswire.com
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -0.53%
H: 5.04%
C: -6.37%
ALLO | $3.48 0.58% 0.57% 2M
|
Health Technology
|
| O: -1.16%
H: 2.41%
C: -5.41%
financial results cel report results
Canopy Biosciences Launches Next-Generation ChipCytometry™ Instrument for Spatial Biology with Sub-Cellular Resolution
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: 1.56%
H: 1.66%
C: 1.01%
chip cel bioscience
Alaska Airlines and our oneworld partners celebrate arriving in style at our home airport
Published: 2022-03-03 (Crawled : 20:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -9.47%
H: 0.0%
C: 0.0%
ALK | $45.01 1.28% -0.07% 3.1M
|
Transportation
|
| O: -2.57%
H: 0.9%
C: -1.92%
air cel one
Aravive Announces Positive Updated Data and New Biomarker Data from Phase 1b Study of Batiraxcept in Clear Cell Renal Cell Carcinoma
Published: 2022-03-03 (Crawled : 19:00) - biospace.com/
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 7.01%
H: 3.06%
C: -5.24%
renal phase 1b cel phase 1 positive biomarkers phase 2b cell carcinoma
Cell Culture Media Market worth $10.3 billion by 2026 - Exclusive Report by MarketsandMarkets™
Published: 2022-03-03 (Crawled : 17:00) - prnewswire.com
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
GLW M | $31.27 1.17% 0.0% 4.6M
|
Electronic Technology
|
| O: -0.2%
H: 0.75%
C: -0.28%
cel media report
ArcelorMittal halts production at its Ukrainian steelmaking operations
Published: 2022-03-03 (Crawled : 16:00) - globenewswire.com
AMSYF | $26.89 -10.71% 200
|
Non-Energy Minerals
|
| O: 2.53%
H: 0.0%
C: 0.0%
MT | $25.39 0.95% 0.0% 1.3M
|
Non-Energy Minerals
|
| O: 0.76%
H: 0.0%
C: 0.0%
cel
MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
Published: 2022-03-03 (Crawled : 15:00) - globenewswire.com
INKT | $0.898 3.02% 2.93% 40K
|
|
| O: -0.35%
H: 8.8%
C: 2.82%
therapeutics cel therapy cancer
Entos Pharmaceuticals Announces Senior Leadership Appointments to Expand Executive Team and Accelerate Growth
Published: 2022-03-03 (Crawled : 14:30) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.08%
H: 1.86%
C: 1.5%
LJPC | $6.22 0.0%
|
Health Technology
|
| O: 1.9%
H: 1.63%
C: -2.33%
als ces cel growth
Accelerate Legacy EDW Migrations with Snowflake Scripting, Now in Public Preview
Published: 2022-03-03 (Crawled : 14:00) - snowflake.com
SNOW | News | $145.45 -1.99% -0.08% 5M
|
Technology Services
|
| O: -16.09%
H: 4.74%
C: 0.27%
cel
Autolus Therapeutics Announces Publication Describing Novel Cell Programming Technology
Published: 2022-03-03 (Crawled : 13:30) - biospace.com/
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 5.41%
H: 1.03%
C: -6.15%
program technology therapeutics cel
Meijer Accelerates its Commitment to Reducing Carbon Emissions 50 Percent by 2025 with Renewable Solar Project
Published: 2022-03-03 (Crawled : 13:30) - prnewswire.com
DUK | News | $98.24 2.41% 0.0% 4.1M
|
Utilities
|
| O: 1.4%
H: 1.96%
C: 1.37%
solar renewable cel
Global Home Healthcare Software Product and Service Markets, 2022-2026 - Rising Healthcare Costs Accelerates the Shift to Low Cost Alternate Care Sites Including Patient Centered Medical Homes
Published: 2022-03-03 (Crawled : 13:30) - prnewswire.com
CERN | $94.92 0.03%
|
Technology Services
|
| O: 0.14%
H: 0.14%
C: -0.14%
health ce mark thc cel software
BioLineRx Announces Additional Positive Results from Pharmacoeconomic Study Comparing Motixafortide + G-CSF to Plerixafor + G-CSF in Stem Cell Mobilization
Published: 2022-03-03 (Crawled : 13:00) - biospace.com/
BLRX | $0.6564 2.55% 2.48% 190K
|
Health Technology
|
| O: 2.53%
H: 3.09%
C: -3.09%
cel positive results stem cell csf positive
Cell Therapy Market 2022-2026 | Increasing Prevalence of Chronic Diseases to Boost Growth | Technavio
Published: 2022-03-03 (Crawled : 11:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: -0.06%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.78%
H: 1.63%
C: 1.5%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -0.64%
H: 2.09%
C: -2.25%
disease cel therapy growth
Immuno-oncology Cell Therapy Market worth $34.69 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-03 (Crawled : 10:00) - prnewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -1.01%
H: 0.41%
C: -6.56%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -13.26%
cel report therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
DBRG | $17.3 0.06% 1.97% 1.2M
|
Finance and Insurance
OSK 4 | $117.72 0.05% 1.96% 370K
|
Producer Manufacturing
HYLN 4 | $1.29 -2.27% 1.55% 680K
|
Producer Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.